| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8943975 | Annales Pharmaceutiques Françaises | 2018 | 7 Pages |
Abstract
Clotting factors represent the most part of the cost of hospitalization of a haemophiliac. Their cost in hospitalization varies according to many factors. It may evolve with the arrival of long-acting clotting factors.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
P. Randuineau, N. Stieltjes, V. Perut, P. Paubel, I. Lopez,